Oncology & Cancer

Zenocutuzumab shows clinical benefit in rare bile duct cancer

Zenocutuzumab (Bizengri), a bispecific antibody that targets human epidermal growth factor receptor 2 (HER2) and HER3, led to responses in more than a third of patients with neuregulin 1 (NRG1)-positive cholangiocarcinoma, ...

Diseases, Conditions, Syndromes

Common toxin linked to liver disease

Liver disease is usually caused by one of three factors: alcohol consumption, fat buildup in the liver linked to obesity, diabetes and high cholesterol, or hepatitis B and C.

page 35 from 40